Login
Manage Portfolio
Post a StockTalk
Write an Instablog
Get Daily Email Alert
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
EP Vantage
»
Articles
|
EP Vantage
62
Followers
2
Following
You are currently following EP Vantage
Stop Following
You are no longer following EP Vantage
Profile
Articles (71)
Instablog (
6
)
Sort by:
Latest
|
Editors' Picks
|
Most Commented
|
Most Popular
NeurogesX: Next Stop, U.S. Market
on Nov 19, 2009
•
ALPMF.PK
,
NGSX
Poniard Pharmaceuticals' Gamble Doesn't Pay Off
on Nov 18, 2009
•
PARD
Direction of Cholesterol Debate Could Benefit Abbott Labs
on Nov 16, 2009
•
ABT
,
AZN
,
GSK
Hemispherx Biopharma: Investors Growing Tired of CFS Drug Delays
on Nov 09, 2009
•
HEB
Johnson & Johnson: The Elephant in the Merck-Schering Living Room
on Nov 04, 2009
•
JNJ
,
MRK
,
SGP
Trial Results Bode Well for Human Genome Sciences
on Nov 02, 2009
•
GSK
,
HGSI
,
IMMU
Transcept Pharma Loses Sleep over Insomnia Drug Approval
on Nov 01, 2009
•
ALXA
,
NVD
,
SOMX
SuperGen-Glaxo Deal Couldn't Have Come at a Better Time
on Oct 27, 2009
•
CELG
,
ESALY.PK
,
GSK
Tough Decisions for Antigenics
on Oct 22, 2009
•
AGEN
,
GSK
,
JNJ
Progenics: Investors Are Right To Be Wary
on Oct 14, 2009
•
AZN
,
NKTR
,
PGNX
OncoGenex: Room for Further Growth?
on Oct 08, 2009
•
BAYRY.PK
,
CGRB
,
DNDN
Immunomedics Gets a Lot of Things Right
on Oct 03, 2009
•
HGSI
,
IMMU
,
RHHBY.PK
Amgen Takes on BMY in Battle of the Cancer Antibodies
on Sep 25, 2009
•
AMGN
,
BMY
,
MRK
Glaxo Could Find Reasons to Extend Its Alliance with Dr. Reddy's
on Sep 22, 2009
•
APNHF.PK
,
GSK
,
PFE
XenoPort's Most Recent Data Points to Larger Opportunity
on Sep 18, 2009
•
GSK
,
XNPT
Elan Pays Price for Secret J&J Deal
on Sep 15, 2009
•
BIIB
,
ELN
,
JNJ
Glaxo's U.S. Cervarix Approval More Important for Company's Pride than for Sales
on Sep 11, 2009
•
GSK
,
MRK
Facet Biotech Should Dig in Its Heels over Biogen Bid
on Sep 08, 2009
•
BIIB
,
FACT
Market Jitters Affect Allos
on Sep 06, 2009
•
ALTH
Brilinta Data Should Soothe Some of AstraZeneca's Patent Cliff Woes
on Sep 02, 2009
•
AZN
,
BMY
,
DSKYY.PK
Dainippon Sumitomo Picks a Hard Fight for Its First U.S. Foray
on Aug 27, 2009
•
DNPUF.PK
,
JNJ
,
LLY
Biovail Makes Good on Promise to Transform into Niche Player in CNS Diseases
on Aug 24, 2009
•
ACAD
,
BVF
,
SPHDF.PK
Lilly's Arzoxifene Defeat: Pharma Giant's Pipeline Looks Awfully Dry Now
on Aug 20, 2009
•
AMGN
,
LLY
Genmab Punished as Arzerra Stumbles in Pivotal Trial - Glaxo Also Affected
on Aug 18, 2009
•
GNMSF.PK
,
GSK
,
RHHBY.PK
Astellas' Current Setback Underscores Need for Pipeline Expansion
on Aug 13, 2009
•
ALPMF.PK
,
NVS
Onyx Signaling Appetite for Deals
on Aug 11, 2009
•
ONXX
Elan / Johnson & Johnson Deal Going Through More Twists and Turns
on Aug 08, 2009
•
BIIB
,
ELN
,
JNJ
ViroPharma Finally Able to Look Forward
on Aug 06, 2009
•
VPHM
New Diabetes Drug Could Give Januvia Stiff Competition
on Aug 04, 2009
•
AZN
,
BMY
,
MRK
Once Again, Savient Disappoints Investors
on Aug 04, 2009
•
SVNT
Inovio Shares Surge on News of Experimental Flu Vaccine Approach
on Aug 04, 2009
•
INO
,
PFE
,
VICL
United Therapeutics: Gold Star Performance as Second FDA Approval Confirmed
on Aug 02, 2009
•
UTHR
1
2
3
Next Page
Articles by Ticker
ABBI
,
ABT
,
ACAD
,
ACL
,
AGEN
,
ALKS
,
ALO
,
ALPMF.PK
,
ALTH
,
ALXA
,
AMGN
,
AMLN
,
APNHF.PK
,
ARKTF.PK
,
AZN
,
BAYRY.PK
,
BIIB
,
BMRN
,
BMY
,
BOMSF.PK
,
BPA
,
BVF
,
BYERF.PK
,
CEGE
,
CELG
,
CEPH
,
CGRB
,
CRXL
,
CVTX
,
DDSS
,
DNA
,
DNDN
,
DNPUF.PK
,
DSKYY.PK
,
EFJI
,
ELN
,
ENDP
,
ESALY.PK
,
FACT
,
FVRL
,
GILD
,
GNMSF.PK
,
GSK
,
HEB
,
HGSI
,
HLUKY.PK
,
HSP
,
HTSUF.PK
,
IMCL
,
IMMU
,
INGN
,
INO
,
IVAC
,
JNJ
,
KG
,
LJPC
,
LLY
,
MEDX
,
MRK
,
MTZXF.PK
,
MYGN
,
MYL
,
NGSX
,
NKTR
,
NOVN
,
NSRGY.PK
,
NVD
,
NVO
,
NVS
,
OGXI
,
ONXX
,
OPHLF.PK
,
PARD
,
PDLI
,
PFE
,
PGNX
,
RBXLF.PK
,
RDY
,
RHHBY.PK
,
RIGL
,
ROG
,
SCMP
,
SGIOF.PK
,
SGP
,
SNY
,
SOMX
,
SPHDF.PK
,
SUPG
,
SVNT
,
SVYSY.PK
,
TKPHF.PK
,
TSPT
,
UCBJF.PK
,
UTHR
,
VICL
,
VNDA
,
VPHM
,
WYE
,
XNPT
,
ZGEN
Latest Comments on EP Vantage's Articles
InvestmentGuru
on
Poniard Pharmaceuticals' Gamble Doesn't Pay Off
: CEO JM is a gambler and should be put behind bars for not...
more »
Justin M. Hall
on
NeurogesX: Next Stop, U.S. Market
: EP: Thank you for the heads up on NGSX. Justin
more »
jay brebner
on
Poniard Pharmaceuticals' Gamble Doesn't Pay Off
: spear was a very risky trial given the way it was designed. their...
more »
northernerx
on
Direction of Cholesterol Debate Could Benefit Abbott Labs
: There are (at least) two components of HDL. Niaspan raises levels...
more »
psusense
on
Hemispherx Biopharma: Investors Growing Tired of CFS Drug Delays
: HEB has always been about confusion. They were even trying to jump...
more »
vinthetoolman
on
Hemispherx Biopharma: Investors Growing Tired of CFS Drug Delays
: A fresh angle to know what he means when he writes.. By Adam...
more »
rgard32
on
Hemispherx Biopharma: Investors Growing Tired of CFS Drug Delays
: Wheres the CRL? rofl.....the fda wont give heb a crl until the nda...
more »
Funkystocks
on
Hemispherx Biopharma: Investors Growing Tired of CFS Drug Delays
: If the FDA were serious about denying the application for Ampligen...
more »
Frank Waddell
on
Johnson & Johnson: The Elephant in the Merck-Schering Living Room
: This is a big issue that seems to garner little attention at the...
more »
brunoq_78242
on
Transcept Pharma Loses Sleep over Insomnia Drug Approval
: After re-reading this piece, I would like to comment more clearly...
more »
Frank the Gerbil
on
Transcept Pharma Loses Sleep over Insomnia Drug Approval
: Do you feel that Purdue would actually walk away within the next...
more »
brunoq_78242
on
Transcept Pharma Loses Sleep over Insomnia Drug Approval
: Your concerns about Somaxon's Silenor are completely unwarranted....
more »
Justin M. Hall
on
SuperGen-Glaxo Deal Couldn't Have Come at a Better Time
: EP: I posted this at my...
more »
Justin M. Hall
on
SuperGen-Glaxo Deal Couldn't Have Come at a Better Time
: EP: Thank you for the article on SUPG. I like this company and...
more »
louhazosc
on
Tough Decisions for Antigenics
: Unfortunately in order to accomplish an attempt to meet European...
more »
Latest Comments on EP Vantage's Articles
Latest Comments on EP Vantage's Articles